• HOME
  • NEWS
  • EXPLORE
    • CAREER
      • Companies
      • Jobs
    • EVENTS
    • iGEM
      • News
      • Team
    • PHOTOS
    • VIDEO
    • WIKI
  • BLOG
  • COMMUNITY
    • FACEBOOK
    • INSTAGRAM
    • TWITTER
Friday, August 22, 2025
BIOENGINEER.ORG
No Result
View All Result
  • Login
  • HOME
  • NEWS
  • EXPLORE
    • CAREER
      • Companies
      • Jobs
        • Lecturer
        • PhD Studentship
        • Postdoc
        • Research Assistant
    • EVENTS
    • iGEM
      • News
      • Team
    • PHOTOS
    • VIDEO
    • WIKI
  • BLOG
  • COMMUNITY
    • FACEBOOK
    • INSTAGRAM
    • TWITTER
  • HOME
  • NEWS
  • EXPLORE
    • CAREER
      • Companies
      • Jobs
        • Lecturer
        • PhD Studentship
        • Postdoc
        • Research Assistant
    • EVENTS
    • iGEM
      • News
      • Team
    • PHOTOS
    • VIDEO
    • WIKI
  • BLOG
  • COMMUNITY
    • FACEBOOK
    • INSTAGRAM
    • TWITTER
No Result
View All Result
Bioengineer.org
No Result
View All Result
Home NEWS Science News Cancer

Cancer studies should include overweight, elderly mice

Bioengineer by Bioengineer
June 1, 2016
in Cancer
Reading Time: 3 mins read
0
Share on FacebookShare on TwitterShare on LinkedinShare on RedditShare on Telegram
IMAGE

ST. LOUIS — Researchers should include laboratory mice that are old and obese in their studies of immunotherapy treatments for cancer, according to a review article by Saint Louis University scientists.

“Because most cancer patients are older than 60 years of age, it can be convincingly argued that all preclinical studies testing novel immunotherapies or new combinations should include older mice. Yet this approach is rarely taken,” says Ryan Teague, Ph.D., associate professor of molecular microbiology and immunology at Saint Louis University and the corresponding author of the article.

The article was the Feature Review of the June 2016 issue of “Trends in Immunology.”

The potential of immunotherapy, using the body’s immune system to fight disease, to save the lives of cancer patients is undeniable, Teague says. Yet, he adds, scientists are not using the best animal models to predict the effectiveness of immunotherapy in different populations.

Young, healthy mice are nearly universally used in cancer immunotherapy studies even though the immune system grows less responsive with aging. For example, T-cells, which identify pathogens and destroy them, aren’t as plentiful and can’t mount as robust of an attack as those in a younger person.

“Despite decades of research into the gradual deterioration of the immunity system during aging, this still represents fertile territory for clinically significant discoveries. Direct comparisons of old and young mice in translational preclinical investigation is crucial moving forward,” Teague says.

“Older mice represent imperfect but valuable models for human immune aging, and may prove far more accurate than young mice in predicting the efficacy and potential toxicity of novel cancer immunotherapies in this major patient demographic.”

His paper encourages researchers to use animal models that are young and old, lean and obese, and different in microbiota to better reflect the patient groups that develop cancer.

Research mice are considered elderly if they are between 16 and 24 months of age, Teague says.

Obesity and differing gut microbes can similarly impact using the body’s own immune system as a weapon against cancer, Teague says.

“What determines the success of immunotherapy among diverse patient populations? Insight has come from recent mouse studies revealing that age, obesity and microbiota profoundly influence both natural immunity to cancer and the ability to effectively respond to immunotherapy. This area of investigation is in its infancy, but results are sufficiently compelling to force new thinking into how human cancer immunotherapy is modeled in mice.”

###

Lauryn E. Klevorn and Ryan M. Teague are authors of the paper, “Adapting Cancer Immunotherapy Models for the Real World.” The research was supported by a grant from the National Institutes of Health/National Institute of Allergy and Infectious Diseases (NIH/NIAID; RO1A1087764), a Cancer Research Institute “Clinic and Laboratory Integration Program (CLIP) award and a grant from the Siteman Cancer Center and The Foundation for Barnes-Jewish Hospital to Teague. Klevorn was supported by a Saint Louis University Presidential Graduate Fellowship.

Established in 1836, Saint Louis University School of Medicine has the distinction of awarding the first medical degree west of the Mississippi River. The school educates physicians and biomedical scientists, conducts medical research, and provides health care on a local, national and international level. Research at the school seeks new cures and treatments in five key areas: infectious disease, liver disease, cancer, heart/lung disease, and aging and brain disorders.

Media Contact

Nancy Solomon
[email protected]
314-977-8017
@SLU_Official

http://www.slu.edu

The post Cancer studies should include overweight, elderly mice appeared first on Scienmag.

Share12Tweet8Share2ShareShareShare2

Related Posts

β-Elemene’s Therapeutic Promise for Glioma, CNS Diseases

β-Elemene’s Therapeutic Promise for Glioma, CNS Diseases

August 22, 2025
AI Detects Cancer Cases Overlooked by Pathologists

AI Detects Cancer Cases Overlooked by Pathologists

August 22, 2025

Colibactin-Producing E. coli Associated with Elevated Colorectal Cancer Risk in FAP Patients

August 22, 2025

Osimertinib Myotoxicity: FDA Data Reveals Risks

August 22, 2025
Please login to join discussion

POPULAR NEWS

  • blank

    Molecules in Focus: Capturing the Timeless Dance of Particles

    141 shares
    Share 56 Tweet 35
  • New Drug Formulation Transforms Intravenous Treatments into Rapid Injections

    114 shares
    Share 46 Tweet 29
  • Neuropsychiatric Risks Linked to COVID-19 Revealed

    81 shares
    Share 32 Tweet 20
  • Modified DASH Diet Reduces Blood Sugar Levels in Adults with Type 2 Diabetes, Clinical Trial Finds

    60 shares
    Share 24 Tweet 15

About

We bring you the latest biotechnology news from best research centers and universities around the world. Check our website.

Follow us

Recent News

APS PRESS Unveils Third Edition of Cotton Industry’s Premier Diagnostic Reference

Birth Weight Linked to Maternal, Neonatal PFOS Levels

β-Elemene’s Therapeutic Promise for Glioma, CNS Diseases

  • Contact Us

Bioengineer.org © Copyright 2023 All Rights Reserved.

Welcome Back!

Login to your account below

Forgotten Password?

Retrieve your password

Please enter your username or email address to reset your password.

Log In
No Result
View All Result
  • Homepages
    • Home Page 1
    • Home Page 2
  • News
  • National
  • Business
  • Health
  • Lifestyle
  • Science

Bioengineer.org © Copyright 2023 All Rights Reserved.